Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 136 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 104 | 95 | 312 | 4 | 62 | 0.04 | 3.00 |  |
| 135 | Pharmaceutical Visions | journal | 0.100 Q4 | 2 | 0 | 68 | 0 | 0 | 54 | 0.00 | 0.00 | |
| 134 | Prescribers' Journal | journal | 0.101 Q4 | 6 | 0 | 29 | 0 | 0 | 23 | 0.00 | 0.00 | |
| 133 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 3 | 20 | 20 | 2 | 12 | 0.10 | 6.67 | |
| 132 | Pharmacology Reviews and Communications | journal | 0.104 Q4 | 9 | 0 | 60 | 0 | 8 | 60 | 0.14 | 0.00 | |
| 131 | Manufacturing Chemist | trade journal | 0.106 Q4 | 6 | 0 | 1433 | 0 | 2 | 58 | 0.00 | 0.00 | |
| 130 | Pharmacy in Practice | journal | 0.108 Q4 | 6 | 51 | 67 | 412 | 5 | 52 | 0.07 | 8.08 | |
| 129 | Journal of Applied Therapeutic Research | journal | 0.113 Q4 | 8 | 18 | 8 | 301 | 1 | 8 | 0.00 | 16.72 | |
| 128 | Cutaneous and Ocular Toxicology | journal | 0.117 Q4 | 37 | 20 | 77 | 603 | 7 | 66 | 0.06 | 30.15 | |
| 127 | Journal of Negative Results in BioMedicine | journal | 0.121 Q4 | 25 | 4 | 3 | 59 | 4 | 1 | 1.33 | 14.75 | |
| 126 | DARU, Journal of Pharmaceutical Sciences | journal | 0.123 Q4 | 58 | 32 | 61 | 645 | 13 | 60 | 0.23 | 20.16 | |
| 125 | Pharmaceutical News | journal | 0.124 Q4 | 11 | 0 | 167 | 0 | 28 | 144 | 0.14 | 0.00 | |
| 124 | Current Drug Discovery | journal | 0.127 Q4 | 13 | 130 | 174 | 17 | 30 | 110 | 0.17 | 0.13 | |
| 123 | International Journal of Geriatric Psychopharmacology | journal | 0.127 Q3 | 11 | 0 | 18 | 0 | 4 | 18 | 0.00 | 0.00 | |
| 122 | IDrugs : the investigational drugs journal | journal | 0.132 Q4 | 39 | 234 | 300 | 3665 | 60 | 300 | 0.17 | 15.66 | |
| 121 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.135 Q4 | 5 | 0 | 35 | 0 | 9 | 30 | 0.00 | 0.00 | |
| 120 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.138 Q3 | 8 | 17 | 49 | 1231 | 15 | 47 | 0.00 | 72.41 | |
| 119 | American Journal of Respiratory Medicine | journal | 0.140 Q4 | 34 | 42 | 51 | 3646 | 14 | 45 | 0.27 | 86.81 | |
| 118 | Quality Assurance Journal | journal | 0.140 Q3 | 11 | 28 | 89 | 184 | 6 | 76 | 0.09 | 6.57 | |
| 117 | Drugs in R and D | journal | 0.149 Q4 | 54 | 75 | 89 | 1026 | 36 | 71 | 0.40 | 13.68 | |
| 116 | Toxicology Mechanisms and Methods | journal | 0.152 Q4 | 55 | 35 | 80 | 1447 | 39 | 79 | 0.39 | 41.34 | |
| 115 | Pharmacology and Toxicology, Supplement | journal | 0.155 Q3 | 7 | 0 | 10 | 0 | 3 | 9 | 0.00 | 0.00 | |
| 114 | Toxicology Methods | journal | 0.156 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 113 | Pharmaceutical Journal | journal | 0.182 Q3 | 28 | 2523 | 4085 | 1159 | 161 | 612 | 0.03 | 0.46 | |
| 112 | Comments on Toxicology | journal | 0.184 Q4 | 13 | 12 | 47 | 466 | 12 | 41 | 0.26 | 38.83 | |
| 111 | Pharmacy and Pharmacology Communications | journal | 0.185 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 110 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.186 Q3 | 25 | 0 | 65 | 0 | 47 | 41 | 0.68 | 0.00 | |
| 109 | Paediatric and Perinatal Drug Therapy | journal | 0.186 Q3 | 20 | 16 | 48 | 413 | 17 | 41 | 0.35 | 25.81 | |
| 108 | Expert Review of Vaccines | journal | 0.190 Q3 | 105 | 78 | 57 | 5374 | 27 | 53 | 0.47 | 68.90 | |
| 107 | Toxic Substance Mechanisms | journal | 0.205 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 106 | Toxin Reviews | journal | 0.227 Q3 | 54 | 43 | 47 | 2070 | 41 | 41 | 0.77 | 48.14 | |
| 105 | Journal of Clinical Research | journal | 0.229 Q3 | 12 | 2 | 18 | 27 | 21 | 18 | 1.33 | 13.50 | |
| 104 | Chemical Speciation and Bioavailability | journal | 0.252 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 103 | Pharmaceutical Medicine | journal | 0.265 Q3 | 25 | 24 | 158 | 324 | 49 | 110 | 0.33 | 13.50 | |
| 102 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
| 101 | ATLA Alternatives to Laboratory Animals | journal | 0.269 Q3 | 65 | 55 | 242 | 1901 | 182 | 208 | 0.72 | 34.56 | |
| 100 | Immunopharmacology and Immunotoxicology | journal | 0.274 Q3 | 61 | 52 | 143 | 1625 | 129 | 143 | 0.97 | 31.25 | |
| 99 | International Journal of Cosmetic Science | journal | 0.284 Q2 | 77 | 31 | 128 | 925 | 83 | 122 | 0.44 | 29.84 | |
| 98 | Journal of Liposome Research | journal | 0.287 Q2 | 64 | 24 | 96 | 453 | 68 | 88 | 0.59 | 18.88 | |
| 97 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.299 Q3 | 92 | 71 | 151 | 1890 | 142 | 150 | 0.87 | 26.62 | |
| 96 | Autonomic and Autacoid Pharmacology | journal | 0.306 Q3 | 24 | 34 | 35 | 1482 | 11 | 34 | 0.31 | 43.59 | |
| 95 | International Antiviral News | journal | 0.307 Q3 | 8 | 0 | 48 | 0 | 27 | 38 | 0.08 | 0.00 | |
| 94 | Toxicology and Industrial Health | journal | 0.312 Q3 | 69 | 20 | 113 | 503 | 74 | 109 | 0.42 | 25.15 | |
| 93 | Pharmaceutical Biology | journal | 0.323 Q2 | 88 | 123 | 286 | 2727 | 142 | 285 | 0.49 | 22.17 | |
| 92 | Journal of Chemotherapy | journal | 0.332 Q3 | 56 | 111 | 375 | 2964 | 400 | 346 | 1.09 | 26.70 | |
| 91 | Journal of Food Biochemistry | journal | 0.332 Q3 | 64 | 31 | 104 | 1195 | 61 | 104 | 0.61 | 38.55 | |
| 90 | BMC Clinical Pharmacology | journal | 0.336 Q3 | 43 | 4 | 12 | 156 | 16 | 12 | 1.33 | 39.00 | |
| 89 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.338 Q3 | 54 | 116 | 348 | 2128 | 260 | 347 | 0.89 | 18.34 | |
| 88 | Fundamental and Clinical Pharmacology | journal | 0.367 Q3 | 85 | 76 | 171 | 3587 | 207 | 166 | 1.17 | 47.20 | |
| 87 | Acta Pharmacologica Sinica | journal | 0.387 Q3 | 117 | 208 | 650 | 4034 | 634 | 649 | 0.90 | 19.39 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data